Adagio Medical Holdings, Inc.

ADGMNASDAQHealthcare● Active

$0.74

+$0.02(+2.57%)

Market Cap$11319244

P/E Ratio—

52W High$2.582

52W Low$0.7

Avg Volume134K

Open$0.75

Beta-0.19

Earnings Financials Revenue

Adagio Medical Holdings, Inc. (ADGM) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

ADGM · earnings · updated Jun 8, 2026

Latest Earnings

Q2 FY2026Report Date: May 12, 2026

EPS Actual

-$0.31

Est. -$0.36 · +13.9%

Revenue

—

Fiscal Period

Q2 FY2026

FY ends December

Report Date

May 12, 2026

After Market Close

▲ Beat EPS✓ 2-Quarter EPS Beat Streak

ADGM reports quarterly as a NASDAQ-listed Medical - Devices company. Fiscal year ends in December. Data: FMP · Updated hourly.

Next Earnings Date

Days Away

days

Expected Date

Sep 1, 2026

Fiscal Period

Q3 FY2026

Release Time

◌ Time TBD (Unconfirmed)

EPS Est.

—

Rev. $0.58B

Days Away85

Expected DateSep 1, 2026

Fiscal PeriodQ3 FY2026

Release TimeTime TBD (Unconfirmed)

EPS Est.—

Rev. Est.$0.58B

EPS & Revenue vs. Estimates

Actual (Beat)

Actual (Miss)

Estimated

Earnings History

Period	Report Date	EPS Est.	EPS Actual	EPS Surpr.	Revenue	Rev. Est.	Rev. Surpr.
◌ Q3 FY2026	Aug 12, 2026	-$0.31	—	—	—	—	—
▲ Q2 FY2026	May 12, 2026	-$0.36	-$0.31	+13.9%	—	—	—
▲ Q1 FY2026	Mar 27, 2026	-$0.31	-$0.21	+32.3%	—	—	—
▼ Q4 FY2025	Nov 12, 2025	-$0.43	-$0.66	-53.5%	—	—	—
— Q3 FY2025	Aug 13, 2025	—	-$0.35	—	—	—	—
— Q2 FY2025	May 15, 2025	—	-$0.50	—	—	—	—

Q3 FY2026

Aug 12, 2026

EPS Actual

—

EPS Est.

-$0.31

EPS Surpr.

—

Revenue

—

Q2 FY2026

May 12, 2026Beat

EPS Actual

-$0.31

EPS Est.

-$0.36

EPS Surpr.

+13.9%

Revenue

—

Q1 FY2026

Mar 27, 2026Beat

EPS Actual

-$0.21

EPS Est.

-$0.31

EPS Surpr.

+32.3%

Revenue

—

Q4 FY2025

Nov 12, 2025Miss

EPS Actual

-$0.66

EPS Est.

-$0.43

EPS Surpr.

-53.5%

Revenue

—

Q3 FY2025

Aug 13, 2025

EPS Actual

-$0.35

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q2 FY2025

May 15, 2025

EPS Actual

-$0.50

EPS Est.

—

EPS Surpr.

—

Revenue

—

Analyst Estimates

Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.

EPS Estimates

Period	Low	Consensus	High	# Analysts
Q4 FY2028	$-0.08	$-0.08	$-0.08	1
Q3 FY2028	$-0.08	$-0.08	$-0.08	1
Q2 FY2028	$-0.08	$-0.08	$-0.08	1
Q1 FY2028	$-0.13	$-0.13	$-0.13	1
Q4 FY2027	$-0.43	$-0.43	$-0.43	1
Q3 FY2027	$-0.36	$-0.36	$-0.36	1

Revenue Estimates

Period	Low	Consensus	High	# Analysts
Q4 FY2028	$0.0B	$0.0B	$0.0B	1
Q3 FY2028	$0.0B	$0.0B	$0.0B	1
Q2 FY2028	$0.0B	$0.0B	$0.0B	1
Q1 FY2028	$0.0B	$0.0B	$0.0B	1
Q4 FY2027	$0.0B	$0.0B	$0.0B	1
Q3 FY2027	$0.0B	$0.0B	$0.0B	1

Earnings Price Reaction

Closing price one trading day before vs. one trading day after each earnings release.

Period	Report Date	EPS Beat/Miss	Price Before	Price After	1D Reaction
▲ Q2 FY2026	May 12, 2026	+13.9%	$0.94	$0.92	-1.83%
▲ Q1 FY2026	Mar 27, 2026	+32.3%	$1.24	$1.22	-1.61%
▼ Q4 FY2025	Nov 12, 2025	-53.5%	$0.87	$0.85	-2.89%
— Q3 FY2025	Aug 13, 2025	—	$1.29	$1.27	-1.55%
— Q2 FY2025	May 15, 2025	—	$1.22	$1.22	+0.00%

Q2 FY2026-1.83%

Report Date

May 12, 2026

EPS Beat/Miss

+13.9%

Price Before

$0.94

Price After

$0.92

Q1 FY2026-1.61%

Report Date

Mar 27, 2026

EPS Beat/Miss

+32.3%

Price Before

$1.24

Price After

$1.22

Q4 FY2025-2.89%

Report Date

Nov 12, 2025

EPS Beat/Miss

-53.5%

Price Before

$0.87

Price After

$0.85

Q3 FY2025-1.55%

Report Date

Aug 13, 2025

EPS Beat/Miss

—

Price Before

$1.29

Price After

$1.27

Q2 FY2025+0.00%

Report Date

May 15, 2025

EPS Beat/Miss

—

Price Before

$1.22

Price After

$1.22

Avg Beat Reaction-1.72%

Avg Miss Reaction-2.89%

Beat Rate2 / 5 quarters

Largest Move-2.89% (Q4 FY2025)

Data: FMP /historical-price-eod/full · field: close

About Earnings & Data Methodology

Adagio Medical Holdings, Inc. (ADGM) most recently reported earnings on May 12, 2026 for Q2 FY2026, posting EPS of $-0.31 — beating the analyst consensus of $-0.36 by +13.9%. ADGM has beaten EPS estimates for 2 consecutive quarters. The next ADGM earnings date is expected around September 1, 2026.

Each quarter, investors track ADGM earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. ADGM revenue tab →

Earnings Glossary

EPS (Earnings Per Share)

Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.

Earnings Surprise %

(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.

Beat / Miss / In-Line

Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.

BMO / AMC

Before Market Open / After Market Close. Two windows when companies typically release results.

Fiscal Quarter

ADGM's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.

Analyst Consensus

Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.

Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Revenue Price history Financial statements Forecast Dividends Market cap

Frequently asked questions

ADGM earnings · 5 questions

Adagio Medical Holdings, Inc.'s next earnings report is expected around September 1, 2026. ADGM typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; ADGM historically reports after market close (AMC).

ADGM earnings datewhen is ADGM earningsADGM next earnings datewhen does ADGM report earningsADGM earnings calendar

▸ Source: FMP · Adagio Medical Holdings, Inc. SEC filings · US GAAP · Adagio Medical Holdings, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026